Join
Live feed
·
INSIDERFilingvia Quantisnow
Beta Bionics Inc. logo

Amendment: Chief Commercial Officer Hopman Mark sold $664,550 worth of shares (35,994 units at $18.46) as part of a pre-agreed trading plan, decreasing direct ownership by 29% to 88,033 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BBNX· Beta Bionics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBNX (Beta Bionics Inc.) and more on Quantisnow.